IFN-γ can activate the JAK-STAT signaling pathway through interferon receptors acting on tumor cells, thereby upregulating the expression of interferon-stimulated genes (ISGs) and enhancing major histocompatibility complex I (MHC-I) expression on the cell membrane. The gene discussed is IFNG; the disease is neoplasm.